The Studies of CBD On:
Diabetes

U.S. NATIONAL LIBRARY OF MEDICINE

NATIONAL INSTITUTE OF HEALTH

"CBD treatment significantly reduced oxidative stress; decreased the levels of tumor necrosis factor-alpha, vascular endothelial growth factor, and intercellular adhesion molecule-1; and prevented retinal cell death and vascular hyperpermeability in the diabetic retina. Consistent with these effects, CBD treatment also significantly inhibited p38 MAP kinase in the diabetic retina. These results demonstrate that CBD treatment reduces neurotoxicity, inflammation, and BRB breakdown in diabetic animals through activities that may involve inhibition of p38 MAP kinase."

U.S. NATIONAL LIBRARY OF MEDICINE

NATIONAL INSTITUTE OF HEALTH

"CBD is not psychoactive and has anti-inflammatory and anti autoimmune properties. Based on the above presented results, on the previously documented anti-inflammatory effects of CBD (Malfait et al., 2000) and on its clinical safety (Cunha et al., 1980), it seems reasonable to consider the use of CBD for controlling type 1 diabetes at an early stage of the disease."

HERB

"2008 study found that CBD delayed insulitis, the term for when immune cells attack insulin-producing cells in the pancreas. The same study also found decreased inflammatory markers. In fact, CBD treatment seemed to shift immune response to from pro-inflammatory to anti-inflammatory. This tentatively corrects an immune imbalance that contributes to autoimmune disease in animal models."

TRY IT FOR YOURSELF

Untitled.jpg
Untitled.jpg
Untitled.jpg

ABOUT

CONTACT US

SHOP

  • Skyline Isolations Instagram
  • Skyline Isolations Facebook
  • Skyline Pinterest
  • Skyline Isolations LinkedIn
  • Skyline Isolations Twitter

© 2017 by Skyline Isolations

DISCLAIMER: SKYLINE DOES NOT MAKE ANY CLAIMS, BUT DISCUSSES PUBLICLY AVAILABLE ANECDOTAL EVIDENCE, RESOURCES AND BOTH EDUCATIONAL AND MEDICAL JOURNALS.